Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Development of a short form and scoring algorithm from the validated actionable bladder symptom screening tool.
Development and validation of the actionable bladder symptom screening tool for multiple sclerosis patients.
Robust Non-Local Multi-Atlas Segmentation of the Optic Nerve.
Multiple sclerosis: Hematopoietic stem cell transplantation: hope and hype.
The insulin-like growth factor system in multiple sclerosis.
HIV and lower risk of multiple sclerosis: beginning to unravel a mystery using a record-linked database study.
Meningeal inflammation and demyelination in a patient clinically diagnosed with acute disseminated encephalomyelitis.
[Pelvic floor muscles training, electrical stimulation, bladder training and lifestyle interventions to manage lower urinary tract dysfunction in multiple sclerosis: A systematic review].
Quantitative analysis of the suppressors of cytokine signaling 1 and 3 in peripheral blood leukocytes of patients with multiple sclerosis.
Aquaporin-4 autoimmunity masquerading as a brainstem tumor.
Suppression of Th1-mediated autoimmunity by embryonic stem cell-derived dendritic cells.
Control of Human PLP1 Expression Through Transcriptional Regulatory Elements and Alternatively Spliced Exons in Intron 1.
Orienting network dysfunction in progressive multiple sclerosis.
Registers of multiple sclerosis in Denmark.
Autoimmune Thyroid Disease in the Use of Alemtuzumab for Multiple Sclerosis: A Review.
Distal acquired demyelinating symmetric neuropathy associated with colorectal adenocarcinoma: Should it be termed paraneoplastic?
Interleukin-17A Levels Vary in Relapsing-Remitting Multiple Sclerosis Patients in Association with Their Age, Treatment and the Time of Evolution of the Disease.
Dimethyl Fumarate: A Review in Relapsing-Remitting MS.
Intracerebroventricular administration of TNF-like weak inducer of apoptosis induces depression-like behavior and cognitive dysfunction in non-autoimmune mice.
A confusing case of multiple sclerosis and central nervous system graft versus host disease.
Deficiency in the mRNA export mediator Gle1 impairs Schwann cell development in the zebrafish embryo.
Medication possession ratio: implications of using fixed and variable observation periods in assessing adherence with disease-modifying drugs in patients with multiple sclerosis.
Development and characterization of a non-cell-based assay to assess the presence of neutralizing antibodies to interferon-beta in clinical samples.
Certified occupational therapy assistants.
Demyelinating encephalopathy in adult onset Still's disease: Case report and review of the literatures.
Pages
« first
‹ previous
…
470
471
472
473
474
475
476
477
478
…
next ›
last »